• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

A not-for-profit health and tax policy research organization.

  • Home
  • About Us
    • Mission and History
    • Officers and Trustees
    • Scholars and Staff
    • Who was Galen?
  • Activities
    • Core Activities
    • State Leaders Calls
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Donate
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Paul Howard: FDA, measure (and improve) thyself

POSTED BY Galen Institute on April 23, 2014.

The Hill, April 23,  2014

The U.S. Food and Drug Administration is arguably the most important regulatory agency in the country—regulating everything from the safety of imported seafood to the latest medicines developed for cancer and Parkinson’s. Yet when things go well, FDA Commissioner Margaret Hamburg typically hears little praise from Congress and the media. But when crisis—real or perceived— strikes in food or drug safety, the agency faces withering criticism on the Hill.

There’s got to be a better way to routinely evaluate the FDA’s performance than trial by crises.  The agency, after all, is enormously complex (with nearly 15,000 employees and dozens of centers and divisions), and like any complex organization, performance across divisions is bound to vary significantly.

Continue Reading…

Filed Under: Uncategorized

Primary Sidebar

Our Annual Report

Health Care Choices 20/20:

A Vision for the Future

SEARCH

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute, Inc © 2022; · Log in